- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medpace Holdings Inc (MEDP)
Medpace Holdings Inc stock price live, this page displays NASDAQ MEDP stock exchange data. View the MEDP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medpace Holdings Inc real time stock price chart below.
What Is the Medpace Holdings Inc Stock Price Today?
The Medpace Holdings Inc stock price today is 443.83.
What Is the Stock Symbol for Medpace Holdings Inc?
The stock symbol for Medpace Holdings Inc is ""MEDP.""
What Stock Exchange Does Medpace Holdings Inc Trade On?
Medpace Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Medpace Holdings Inc a Good Stock to Buy?
Determining whether Medpace Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDP quote. (ISIN: US58506Q1094)
What Is the Medpace Holdings Inc Stock Price Today?
The Medpace Holdings Inc stock price today is 443.83.
What Is the Stock Symbol for Medpace Holdings Inc?
The stock symbol for Medpace Holdings Inc is ""MEDP.""
What Stock Exchange Does Medpace Holdings Inc Trade On?
Medpace Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Medpace Holdings Inc a Good Stock to Buy?
Determining whether Medpace Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDP quote. (ISIN: US58506Q1094)
443.83
-9.22(-2.04%)
Real-time Data·
Fair Value
An estimate of a Medpace Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
431.89
444.68
52 wk Range
250.05
501.30
MEDP Scorecard
Full Analysis
Management has been aggressively buying back shares
MEDP is included in our AI-picked strategies. See how they work
Review Strategies
Fair Value
An estimate of a Medpace Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
431.89444.68
52 wk Range
250.05501.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MEDP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Medpace Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
409.82
Downside
-7.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Medpace Holdings Inc Company Profile
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Medpace Holdings Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of $3.10 and revenue of $603.3M surpassed forecasts; stock surged 53.81% to $450
- Revenue up 14.2% YoY; focus on metabolic studies and reduced cancellations drove growth
- Full-year revenue projected at $2.42B-$2.52B; EBITDA forecast $515M-$545M
- CEO expects increased bookings; funding environment stable to improving
- Q3 book-to-bill ratio anticipated above 1.15, signaling strong future bookings
Last Updated: 22/07/2025, 15:26
Read Full TranscriptCompare MEDP to Peers and Sector
Metrics to compare | MEDP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 29.7x | −0.1x | −0.5x | |
PEG Ratio | 1.14 | 0.04 | 0.00 | |
Price/Book | 72.0x | 1.2x | 2.6x | |
Price / LTM Sales | 5.6x | 1.9x | 3.2x | |
Upside (Analyst Target) | −4.3% | 49.5% | 41.2% | |
Fair Value Upside | Unlock | 28.5% | 6.2% | Unlock |
Analyst Ratings
2 Buy
8 Hold
2 Sell
Ratings:
12 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 409.82
(-7.66% Downside)
Earnings
Latest Release
Jul 21, 2025
EPS / Forecast
3.10 / 2.98
Revenue / Forecast
603.30M / 538.81M
People Also Watch
FAQ
What Stock Exchange Does Medpace Holdings Trade On?
Medpace Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Medpace Holdings?
The stock symbol for Medpace Holdings is "MEDP."
What Is the Medpace Holdings Market Cap?
As of today, Medpace Holdings market cap is 12.46B.
What Is Medpace Holdings's Earnings Per Share (TTM)?
The Medpace Holdings EPS (TTM) is 13.83.
When Is the Next Medpace Holdings Earnings Date?
Medpace Holdings will release its next earnings report on 26 Oct 2025.
From a Technical Analysis Perspective, Is MEDP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Medpace Holdings Stock Split?
Medpace Holdings has split 0 times.
How Many Employees Does Medpace Holdings Have?
Medpace Holdings has 6000 employees.
What is the current trading status of Medpace Holdings (MEDP)?
As of 29 Jul 2025, Medpace Holdings (MEDP) is trading at a price of 443.83, with a previous close of 453.05. The stock has fluctuated within a day range of 431.89 to 444.68, while its 52-week range spans from 250.05 to 501.30.
What Is Medpace Holdings (MEDP) Price Target According to Analysts?
The average 12-month price target for Medpace Holdings is USD409.81818, with a high estimate of USD510 and a low estimate of USD300. 2 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an -7.66% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.